Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1635
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18134167 | OLIGONUCLEOTIDES FOR ATN1 MODULATION | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 17577942 | RECOMBINASE COMPOSITIONS AND METHODS OF USE | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18253198 | Systems and Methods for Diagnostic Assessment and Treatment of Insulin Resistance and Hyperglycemia | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 19334058 | USE OF MULTIPLE PROMOTERS EFFICIENTLY TARGETED ON ON-BIPOLAR CELLS IN GENE THERAPY TECHNOLOGY | Non-Final OA | ZHONGMOU THERAPEUTICS CO., LTD. |
| 17961925 | PREDICTION, BIOSYNTHESIS, AND INTEGRATION AS BIOSENSORS OF MOLECULES WITH UNIQUE LIGHT ABSORBANCE SIGNATURES AND THEIR SUBSEQUENT IN-FIELD REMOTE DETECTION USING MULTI OR HYPER-SPECTRAL CAMERAS | Final Rejection | Massachusetts Institute of Technology |
| 17761292 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy